PDSA Documents
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Meetings Member PO Materials
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Meetings Member PO Materials
September is a peak time for asthma attacks in the United States. According to the
INHALE is pleased to share details on a new, free educational resource American Lung Association
Listen and learn from Dr. Reuben Strayer, emergency medicine physician in New York, about how
The report is updated yearly and is based, to the best of the group’s ability,
The 2024 and 2025 timelines are now available, view them here. We have split the
Teva Pharmaceuticals is discontinuing its series of digital inhalers starting June 1, 2024. Teva’s digital
Drug companies Boehringer Ingelheim, AstraZeneca and GSK have announced they are capping out-of-pocket costs for
This toolkit contains a variety of resources to assist providers in giving their patients the information
BCBSM Update BCBSM approves Flovent ABA for members less than 5 years of age. No
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.